CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 14 No. 8
Pages: 1  2  3  
Next
 

Clinical Status of Laparoscopic Bowel Surgery for GI Malignancy

By

Steven D. Wexner, MD, FACS, FRCS, FRCS (Ed)
Chairman, Department of Colorectal Surgery, and Chief of Staff, Cleveland Clinic Florida, University of South Florida College of Medicine, Tampa, Florida
Yong-Hee Hwang, MD
Department of Colorectal Surgery, Cleveland Clinic Florida, Fort Lauderdale, Florida

| August 1, 2000

Laparoscopic colorectal surgery is being utilized increasingly for benign diseases. Recent published series have proven that morbidity and mortality from laparoscopic procedures are superior to those seen after traditional open procedures. However, although the technical feasibility of laparoscopic bowel resections has been confirmed, the oncologic advisability has not. The procedures are not yet standards of care, due to port site recurrences, inadequate lymph node harvest, inadequate resection margins, and level of ligation. At present, laparoscopic bowel resection for cure of malignancy does not confer significant benefits when compared to laparotomy and, indeed, has been associated with some serious problems. Long-term critical evaluation of large numbers of patients in prospective, randomized trials is needed to define any merits of laparoscopy. Until such data become available, laparoscopy for attempted cure of colorectal malignancy should be performed only within the context of peer-reviewed, externally monitored, prospective, randomized trials. However, these techniques are perfectly appropriate for palliation of metastatic disease. [ONCOLOGY 14(8):1131-1143, 2000]



Introduction

Since the introduction of laparoscopic cholecystectomy, nearly every surgical specialty and procedure has incorporated the laparoscope. The theoretical benefits of reduced postoperative pain, length of hospital stay, and early return to work, as well as other benefits, however, have not been universally borne out in laparoscopic colorectal surgery.

Also, laparoscopic colorectal surgery is associated with some major problems: (1) laparoscopic colorectal surgery typically involves multiple quadrants and, therefore, is more technically challenging. Personnel, instruments, monitors, and even the patient are often moved to facilitate access to these quadrants; (2) bowel surgery requires rapid and safe manipulation of numerous, large, often calcified vessels, which are always encased in fat; (3) colonic surgery involves fashioning a well-vascularized, tension-free, circumferentially intact anastomosis, without intraperitoneal contamination; and (4) a major indication for laparoscopic colorectal surgery would be malignancy, and the safety and effectiveness of laparoscopy for this indication are currently unknown.

As technology has improved and the skills of surgeons have become more advanced, laparoscopy has been used by some for diagnosis, palliation, and attempted cure of gastrointestinal (GI) tumors. Laparoscopy for curative resection of malignancy is the most controversial indication for laparoscopic surgery today, because true recurrence and overall cure rates remain unknown.

Laparoscopy for Diagnosis and Palliative Surgery

Laparoscopic ultrasonography in patients with GI malignancy presents a unique opportunity for precise tissue sampling. Moreover, the patient can be offered minimally invasive palliative laparoscopic bypass and diversionary procedures.

In a series by Anderson et al,[1] laparoscopic ultrasonography was significantly more accurate than either conventional computed tomography (CT) or ultrasonography in detecting both primary GI tumors (91% vs 64%; P < .01) and nodal status (91% vs 62%; P < .05). A study by Cuschieri[2] revealed a diagnostic yield of 90%, staging accuracy of 30%, and understaging in 4% of patients.

A recent study by Hünerbein et al[3] revealed that laparoscopy and laparoscopic ultrasound improved the accuracy of staging in 41% of patients with GI cancer, as compared with conventional imaging methods; the accuracy of staging laparoscopy in the detection of distant metastases (68%) was significantly higher (P < .01) than that of ultrasound (63%) or CT scan (58%). The findings during staging laparoscopy changed the treatment strategy in 45% of patients.

The exact role of laparoscopy and laparoscopic ultrasonography in the evaluation of specific intra-abdominal malignancies continues to be evaluated. Its clinical effect depends on the surgeon’s definition of resectability or operability, and also on the availability of and expertise with other imaging modalities at each hospital.[4]

Second-Look Laparoscopy

Second-look laparoscopy in colorectal and other GI cancers is still controversial. Hemming et al[5] reported success in proving peritoneal recurrence of colorectal cancer in two of three laparoscopies in patients with rising tumor markers and normal radiologic studies.

Salky et al[6] also attempted second-look laparoscopy in seven patients with suspected recurrent colon cancer, leading to a positive yield in one with liver metastases and avoidance of surgery in all but two. However, these are small numbers of patients, and further investigation in this area is required before such an approach can be recommended.

Laparoscopic Fecal Diversion

Patients with advanced malignancies may undergo fecal diversion to relieve obstruction, incontinence, complicated fistulas, and severe perianal sepsis. Hashizume and colleagues[7] reported a successful laparoscopic-assisted colostomy for complete obstruction of the sigmoid colon associated with end-stage ovarian cancer.

Laparoscopic fecal diversion obviates the need for a major abdominal incision but does not limit intra-abdominal exploration when a trephine stoma is performed.[8] Laparoscopic fecal diversion is technically simple to perform and requires minimal equipment while allowing excellent visualization and all possible methods of dissection.

Some investigators have advocated that laparoscopic fecal diversion procedures be performed by surgeons with limited experience in laparoscopic intestinal surgery. Laparoscopic colostomy may be associated with a decreased incidence of wound complications, evisceration, and incisional hernia, as compared with laparotomy.

Furthermore, the traditional merits of laparoscopy, such as earlier return to bowel function, decreased pain, and, theoretically, reduced adhesion formation, are advantages of laparoscopic fecal diversion.[8, 9] However, in patients with an acute obstruction and massive bowel dilatation or with free intraperitoneal perforation, a laparotomy may be preferable.[10]

Surgical Considerations

Major colorectal resections may be accomplished in two ways: either by right hemicolectomy for ileocolic resections or by total abdominal colectomy. For the latter, if laparoscopy is utilized, the laparoscopic-assisted technique is preferred. After laparoscopic mobilization, the bowel is exteriorized through a small incision for extracorporeal vascular ligation, resection, and anastomosis.

Although these maneuvers can all be performed within the abdomen, the length of operative time and expense limit their attractiveness. Moreover, since an incision needs to be made for specimen retrieval, it seems logical to also perform the ligation, resection, and anastomosis through that incision.

For left-sided procedures, a completely laparoscopic technique is more logical. In such cases, colonic mobilization, resection, and anastomosis are accomplished in an intracorporeal manner.

Length of the Procedure

Laparoscopic colorectal surgery involves a learning curve, during which operative times of over 2 hours can be expected. Operative time decreases with increasing experience.[11] This improvement seems to be the result of both better surgical technique and better patient selection. The use of the ultrasonic scalpel (Harmonic Scapel, Ethicon Endosurgy Inc, Cincinnati, Ohio) offers a definite advantage for mesenteric dissection and vascular control by potentially allowing adequate hemostasis, decreased operative time, and decreased cost because fewer surgical clips are utilized.

Interference With Tactile Sensation

One of the disadvantages of laparoscopic surgery is that it impairs the surgeon’s tactile sensation and the ability to palpate the bowel. Several reports have described the resection of a segment of bowel thought to contain a tumor or polyp, but the suspected lesion was later discovered in an unresected segment of bowel.[12] Similarly, cases have been reported in which postoperative bowel obstruction requiring laparotomy was caused by an unrecognized synchronous proximal tumor.[13]

This problem can be overcome in a number of ways, including preoperative colonoscopic marking, preoperative air contrast barium enema, or intraoperative colonoscopy. Intraoperative laparoscopic ultrasonography offers the surgeon the ability to palpate the liver and other organs, which is lost during the laparoscopic surgery.

This interference with tactile sensation also makes identification of certain anatomic structures more difficult. Accordingly, ureteric catheters are sometimes used to assist in the identification of the ureters.[14]

Postoperative Adhesions

It has been hypothesized that laparoscopy, given its minimally invasive nature, inherently decreases postoperative adhesion formation.[9] Bessler et al[15] reported a porcine model comparing the incidence of adhesion formation after laparotomy compared with laparoscopic-assisted colon resections. Adhesions were identified 14 days after the initial procedure in only one (9%) of the animals that had laparoscopic-assisted resections, as opposed to 82% of the animals that had a laparotomy.

Recently, as part of a multi-institutional, prospectively randomized, surgeon-blinded trial, we assessed postoperative adhesion formation using a hyaluronate-based membrane.[16] The number and severity of adhesions were significantly decreased when the hyaluronate-based membrane was applied, as compared with the control group, both of which underwent laparotomy. The same advantages may be conferred by using the product during laparoscopic-assisted procedures. Accordingly, we routinely place Seprafilm (Gemzyme Surgical Products, Cambridge, Mass) during all laparoscopic-assisted colectomies.

Pages: 1  2  3  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy